News & Events

News

Read more about our scientific studies as well as our programs, grants and awards.
GRAPPA Study: New Evidence on GvHD Prevention with ATLG in Stem Cell Transplants from Unrelated Donors
Anti-T-lymphocyte globulin (ATLG) for the prevention of graft-versus-host disease (GvHD) reduces complications and infection-related mortality compared to post-transplant cyclophosphamide (PTCy) in allogeneic hematopoietic stem cell transplantation from unrelated donors [1]. Although PTCy was associated with fewer cases of acute (Grade II–IV) and chronic GvHD, this did not result in a survival benefit for patients with blood cancer [1]. These initial results from the GRAPPA study were presented by DKMS as a late-breaking abstract at the European Hematology Association (EHA) Congress in Stockholm.
News
Improving Global Access to Transplantation: A Decade of the DKMS ATT Program
In a recent paper in Blood Global Hematology we reflect on more than ten years of the successful Access to Transplantation (ATT) program, launched by DKMS in 2014. Read more about our activities and what we achieved in the last decade.
News
Honoring Scientific Excellence at the DKMS Awards Night
At the Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Madrid, we came together with leading experts in hematology and transplantation to celebrate scientific excellence and future innovation. Under the theme “35 Years of Science at DKMS,” we presented the 2026 DKMS Mechtild Harf Science Award to Robert Negrin and young scientists were awarded with the DKMS John Hansen Research Grant.

Events

Find here all upcoming events.
-
Listen to the first data on the GRAPPA trial at the EHA 2026 in Stockholm
Stockholmsmässan

In addition to other contributions from DKMS we are happy to announce the presentation of the first data from GRAPPA, a randomized clinical trial comparing PTCy vs ATG, during the EHA Congress 2026 in Stockholm, Sweden.

Presentation: Pro ATG
Prof. Johannes Schetelig (Dresden, Germany)
Date & time: Saturday, 13 June, 16:20- 16:25 CEST (Hall A7)

Presentation: GvHD Prophylaxis including ATG remains Standard of Care for HLA-compatible unrelated donor hematopoietic cell transplantation: results from a large randomized controlled trial comparing ATG and PTCy
Prof. Johannes Schetelig (Dresden, Germany)
Date & time: Saturday, 13 June, 18:15 - 18:30 CEST (Hall A6)


EHA program 2026
-
Find us at at our booth no. 38 at the EBMT 2026 in Madrid
IFEMA Madrid

You can find us at the event venue IFEMA Madrid in Pavillon 9 at booth no. 38. Our DKMS colleagues will be happy to answer your questions, explain our services and affirm our international commitment on site.


EBMT_Flyer.png
Website EBMT 2026
-
We take part in the WMDA Global Meetings 2026 in Madrid
NH Collection Madrid Eurobuilding

You can find our DKMS booth in the exhibition area of the NH Collection Madrid Eurobuilding in Madrid. We look forward to meeting you there!

WMDA_Flyer.png
Website WMDA Global Meetings 2026